Examining the effects of hormone treatment in transgender women and non-binary individuals
Official title: Feminizing Treatment in Transgender Women and Non-binary Persons BODY IDENTITY CLINIC - ESTROGEN
Run by Odense University Hospital · NCT05169762 · Data updated 2026-11-12
This study is testing how hormone treatment affects heart health over time in transgender women and non-binary individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 100 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Odense) |
| Status | Recruiting |
| Started | February 1, 2022 |
| Main results expected | September 1, 2035 |
| Study ends | September 1, 2035 |
| Registry record updated | March 21, 2025 |
| Trial ID | NCT05169762 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are transgender women who have been assigned male at birth and are eligible for gender-affirming feminizing treatment.
✕Probably not a fit
Patients who are not transgender women or non-binary individuals, or those who do not meet the eligibility criteria for hormone treatment, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study involves 100 transgender women receiving gender-affirming hormone treatment. Participants will be followed for outcomes related to cardiovascular health at intervals of 1, 3, 5, and 10 years. The study aims to assess the formation of non-calcified and calcified plaques through coronary CT angiograms, evaluate heart function via echocardiograms, and measure various cardiovascular risk markers in blood and urine. The goal is to better understand the long-term cardiovascular effects of hormone therapy in this population.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the cardiovascular risks associated with hormone treatment, leading to improved health management for transgender individuals.
How similar studies have gone: While there have been studies on hormone treatment in transgender individuals, this specific long-term observational approach focusing on cardiovascular outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * assigned male at birth and eligeble for gender affirming feminizing treatment Exclusion Criteria: none \-
Where it's running
-
OdenseUH
Odense, Denmark Recruiting
Study contacts
- Principal investigator: Dorte Glintborg — Odense University Hospital
- Study coordinator: Dorte Glintborg
- Email: dorte.glintborg@rsyd.dk
- Phone: +4565411807
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How male-level testosterone affects reproductive hormone cycles in people assigned female at birth
This study will test whether male-level testosterone given to transgender men starting hormone therapy changes the ovarian and pituitary hormones that control menstrual cycles compared with cisgender women.
-
Evaluating voice outcomes after gender-affirming voice surgeries
This study is testing how different gender-affirming voice surgeries affect voice quality and patient satisfaction over time.
-
Assessing pelvic changes after vaginoplasty in transgender women
This study is testing how the body changes after vaginoplasty in transgender women to see how well the surgery works and what effects it has over time.
-
Effects of cross-sex hormone therapy on metabolism and eating behavior
This study looks at how cross-sex hormone therapy affects metabolism, eating habits, and overall health in people undergoing this treatment.
-
Effects of Estradiol on Cardiometabolic Health in Transgender Youth
This study tests how estradiol affects insulin sensitivity and blood vessel health in transgender girls aged 13-16 compared to girls who are not transgender.
-
Evaluating puberty suppression effects on health in transgender youth
This study is testing how puberty suppression affects health, like insulin sensitivity and heart health, in transgender girls compared to boys over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.